Early and mid-term results of minimally invasive direct coronary artery bypass (MIDCAB) surgery

Abstract

Aim: This study aimed to evaluate the early and mid-term outcomes of minimally invasive direct coronary artery bypass (MIDCAB) surgery for isolated left anterior descending artery (LAD) disease, with a primary focus on revascularization-free survival.

Methods: A retrospective analysis was conducted on 155 consecutive patients who underwent MIDCAB at Santa Maria Hospital, Bari, Italy, between May 2017 and December 2023. All patients received a direct anastomosis of the left internal thoracic artery (LITA) to the LAD, with sequential grafting performed for those with concurrent diagonal artery disease. The primary endpoint was revascularization-free survival. The secondary endpoint was in-hospital mortality. Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models were employed for statistical analysis.

Results: The median follow-up duration was 36 months [12-48]. No 30-day postoperative deaths occurred. The 5-year revascularization-free survival rate was 84.2% [77.4-91.7], and the overall 5-year survival rate was 90.5% [85.1-96.2]. Predictors of the primary endpoint were preoperative New York Heart Association (NYHA) class III (HR 5.898 [1.187-29.311], P = 0.030) and postoperative atrial fibrillation (HR 3.405 [1.232-9.415], P = 0.018). The incidence of complications was low, with no cerebrovascular events reported.

Conclusion: MIDCAB for isolated LAD disease is safe, with satisfactory postoperative outcomes and excellent mid-term survival. These findings align with existing literature, underscoring the procedure’s reproducibility. Further multicenter studies are needed to validate these results and compare MIDCAB versus PCI in treating isolated LAD disease.

Keywords

Minimally invasive direct coronary artery bypass / medium-term outcomes / myocardial revascularization

References

[1] Head SJ,Falk V,Kappetein AP.Coronary artery bypass grafting: part 1-the evolution over the first 50 years.Eur Heart J2013;34:2862-72

[2] Llerena-Velastegui J,Velastegui-Zurita S.Comparative efficacy of percutaneous coronary intervention versus coronary artery bypass grafting in the treatment of ischemic heart disease: a systematic review and meta-analysis of recent randomized controlled trials.Cardiol Res2024;15:153-68 PMCID:PMC11236347

[3] Kim KM,Habib R.The society of thoracic surgeons adult cardiac surgery database: 2022 update on outcomes and research.Ann Thorac Surg2023;115:566-74

[4] Loop FD,Cosgrove DM.Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.N Engl J Med1986;314:1-6

[5] Cameron A,Green G.Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period.N Engl J Med1996;334:216-9

[6] Repossini A,Nicoli F.Minimally invasive coronary artery bypass: twenty-year experience.J Thorac Cardiovasc Surg2019;158:127-38.e1

[7] Davierwala PM,Bergien L.Twenty-year outcomes of minimally invasive direct coronary artery bypass surgery: the Leipzig experience.J Thorac Cardiovasc Surg2023;165:115-27.e4

[8] Guo MH,Issa H.Long-term survival, cardiovascular, and functional outcomes after minimally invasive coronary artery bypass grafting in 566 patients.J Thorac Cardiovasc Surg2024;168:1080-8.e2

[9] Patel NC,Seetharam K.Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery.J Thorac Cardiovasc Surg2022;163:1839-46.e1

[10] Wyler von Ballmoos MC,Iribarne A.The society of thoracic surgeons adult cardiac surgery database: 2023 update on procedure data and research.Ann Thorac Surg2024;117:260-70

[11] Vrints C,Koskinas KC.2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS).Eur Heart J2024;45:3415-537

[12] Kolesov VI.[Surgery of coronary arteries].Eksp Khir Anesteziol1965;10:3-8

[13] Calafiore AM.Left anterior small thoracotomy (LAST) for coronary artery revascularisation.Lancet1996;347:263-4

[14] Garg S.Minimally invasive direct coronary artery bypass (MIDCAB) grafting.AME Med J2020;5:19

[15] Ruel M,Lapierre H.Results of the minimally invasive coronary artery bypass grafting angiographic patency study.J Thorac Cardiovasc Surg2014;147:203-9

[16] El Adel M, Nady MA, Amin A, Khairy M. A randomized controlled trial (PAMI trial) on our new trend periareolar minimally invasive (PAMI) technique versus inframammary approach for minimally invasive cardiac surgery.Cardiothorac Surg2022;30:29

[17] Raja SG,Alkizwini E,Amrani M.Harefield Cardiac Outcomes Research GroupPropensity score adjusted comparison of MIDCAB versus full sternotomy left anterior descending artery revascularization.Innovations2015;10:174-8

[18] Stanislawski R,Marczak J.Early and long-term clinical outcomes after minimally invasive direct coronary artery bypass grafting versus off-pump coronary surgery via sternotomy in isolated proximal left anterior descending artery disease: a propensity score matching analysis.J Card Surg2020;35:3412-9

[19] Sharaf M,Sunavsky J.Early and late outcomes after minimally invasive direct coronary artery bypass vs. full sternotomy off-pump coronary artery bypass grafting.Front Cardiovasc Med2024;11:1298466 PMCID:PMC10914960

[20] Blazek S,Borger MA.Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.JACC Cardiovasc Interv2015;8:30-8

[21] Raja SG,Garg S.Comparison of minimally invasive direct coronary artery bypass and drug-eluting stents for management of isolated left anterior descending artery disease: a systematic review and meta-analysis of 7,710 patients.Ann Cardiothorac Surg2018;7:567-76 PMCID:PMC6219941

[22] Manuel L,Betts K,Wolfenden H.LIMA to LAD grafting returns patient survival to age-matched population: 20-year outcomes of MIDCAB surgery.Interact Cardiovasc Thorac Surg2022;35:ivac243 PMCID:PMC9519092

[23] Nisivaco S,Bhasin R,Coleman C.A decade of robotic beating-heart totally endoscopic coronary bypass (TECAB) at a single institution: outcomes with 10-year follow-up.J Thorac Cardiovasc Surg2024;S0022-5223(24)00682

[24] Squiccimarro E,Paparella D.Bilateral mini-thoracotomy for combined minimally invasive direct coronary artery bypass and mitral valve repair.Eur J Cardiothorac Surg2022;62:ezac306